Certification of QuantiFERON-TB Gold Plus under more stringent EU regulation, classified under Class C Certification marks milestone in QIAGEN's transition to full compliance with new EU regulations
QuantiFERON franchise benefits from new applications, products and automation options, building on strengths in tuberculosis detection while addressing new disease targets QuantiFERON SARS-CoV-2
Easy-to-use workflow can detect T-cell response early in the course of COVID-19 infection or following vaccination Detection of T-cells can provide vital insights that completes the picture
Additional U.S. approval for LIAISON XS platform builds on FDA approval in 2019 for QuantiFERON assay running on DiaSorin's LIAISON XL analyzer Collaboration now provides full range of automation
AMSTERDAM (dpa-AFX) - QIAGEN (QGEN) and DiaSorin said Monday that the U.S. Food and Drug Administration has approved the LIAISON QuantiFERON-TB Gold Plus assay for use on DiaSorin's automated LIAISON